Amrize furnishes Q3 2025 results press release and investor deck

Rhea-AI Filing Summary

Amrize Ltd furnished an 8-K announcing it issued a press release with financial results for the quarter ended September 30, 2025, and an investor presentation. The materials are furnished under Items 2.02 and 7.01 and made available as Exhibits 99.1 and 99.2, dated October 28, 2025.

The company notes these materials are furnished, not filed, under the Exchange Act and are available on its investor website.

8-K Event Classification

3 items: 2.02, 7.01, 9.01

3 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

FALSE000203598900020359892025-10-282025-10-28

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________________________

FORM 8-K

___________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

October 28, 2025

Date of Report (date of earliest event reported)

___________________________________

Amrize Ltd

(Exact name of registrant as specified in its charter)

___________________________________

Switzerland (State or other jurisdiction of incorporation or organization)			1-42542 (Commission File Number)			98-1807904 (I.R.S. Employer Identification Number)
Grafenauweg 8, Zug 6300
(Address of principal executive offices and zip code)
+41 41 562 3490
(Registrant's telephone number, including area code)

___________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class			Trading Symbol			Name of each exchange on which registered
Ordinary Shares, par value $0.01 per share			AMRZ			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company    ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 2.02 - Results of Operations and Financial Condition

On October 28, 2025, Amrize Ltd (the "Company") issued a press release announcing its financial results for the quarter ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference into this Item 2.02 in its entirety. A copy of the press release will also be available on the Company’s website.

Item 7.01 – Regulation FD Disclosure

To supplement the information in the attached press release, the Company has also prepared an investor presentation, which will be available on the Company’s website at investors.amrize.com/. A copy of the investor presentation is furnished as Exhibit 99.2 to this Current Report on Form 8-K and incorporated by reference into this Item 7.01 in its entirety.

The information in Items 2.02 and 7.01 of this Current Report on Form 8-K, including Exhibits 99.1 and 99.2, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section and shall not be deemed incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 - Financial Statements and Exhibits

(d): The following exhibits are being filed herewith:

Exhibit No.						Description
99.1						Press release dated October 28, 2025
99.2						Investor presentation dated October 28, 2025
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Amrize Ltd
By:			/s/ Ian Johnston
Name:			Ian Johnston
Title:			Chief Financial Officer
Date:			October 28, 2025

FAQ

What did AMRZ announce in its 8-K?

The company furnished a press release with quarterly results for the period ended September 30, 2025, and an investor presentation.

Which 8-K items apply to Amrize (AMRZ)?

Items 2.02 (Results of Operations and Financial Condition) and 7.01 (Regulation FD Disclosure).

Where can I find the Amrize exhibits?

Exhibits 99.1 (press release) and 99.2 (investor presentation) are furnished and available on the company’s investor website.

Are the materials considered filed with the SEC?

No. The Item 2.02 and 7.01 materials are furnished, not filed, and are not subject to Section 18 liabilities.

What is the date of the Amrize press release?

October 28, 2025.

What exchange and symbol does Amrize use?

Amrize’s ordinary shares trade on the NYSE under the symbol AMRZ.